Armen Karamanian
Amministratore Delegato presso Eliksa Therapeutics, Inc.
Profilo
Armen Karamanian is the founder of Eliksa Therapeutics, Inc. and holds the title of Chief Executive Officer since 2021.
Posizioni attive di Armen Karamanian
| Società | Posizione | Inizio |
|---|---|---|
Eliksa Therapeutics, Inc.
 Eliksa Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Eliksa Therapeutics, Inc. is a biotechnology company that develops medicines for debilitating diseases using the regenerative properties of amniotic fluid and amniotic membrane. The company is based in Doylestown, PA. Eliksa Therapeutics was founded by Armen Karamanian, Jane Holmes Hollingsworth, and Armen Karamanian has been the CEO since incorporation. | Amministratore Delegato | 01/07/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Eliksa Therapeutics, Inc.
Eliksa Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Eliksa Therapeutics, Inc. is a biotechnology company that develops medicines for debilitating diseases using the regenerative properties of amniotic fluid and amniotic membrane. The company is based in Doylestown, PA. Eliksa Therapeutics was founded by Armen Karamanian, Jane Holmes Hollingsworth, and Armen Karamanian has been the CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- Armen Karamanian
